戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 line cortisol at 60 min of < 9 mug/dL) after cosyntropin (250 mug) administration and a random plasma
2 efore and 60 minutes after administration of cosyntropin, 250 ug).
3 re (basal) and three times after intravenous cosyntropin (ACTH 1-24) injection.
4                                        Short cosyntropin (adrenocorticotropic hormone; ACTH) stimulat
5 also demonstrated with patients who received cosyntropin, resulting in improved uptake.
6                                  Resting and cosyntropin-stimulated cortisol levels were obtained bef
7          The absolute change in baseline and cosyntropin-stimulated lateralization index (maximum-min
8 he baseline sets, 53 patients (13.2%) within cosyntropin-stimulated sets, and 13 patients (3.2%) in b
9  and 13 patients (3.2%) in both baseline and cosyntropin-stimulated sets.
10 Adrenal insufficiency was determined using a cosyntropin stimulation test in all studies.
11                                          The cosyntropin stimulation test is the initial endocrine ev
12 asia, is in place in many countries, however cosyntropin stimulation testing might be needed to confi
13 ing AVS in triplicate, both before and after cosyntropin stimulation, had intraprotocol discrepancies
14 ty occurring within samples obtained without cosyntropin stimulation.
15 ples obtained between 5 and 30 minutes after cosyntropin stimulation.
16 dary adrenal insufficiency for the high-dose cosyntropin test (P < 0.001), but AUCs for the 250-micro
17                                          The cosyntropin test performs well in patients with primary
18 95%, summary ROC analysis for the 250-microg cosyntropin test yielded a positive likelihood ratio of
19  secondary adrenal insufficiency (250-microg cosyntropin test), and secondary adrenal insufficiency (
20 nd secondary adrenal insufficiency (1-microg cosyntropin test), respectively.
21 or primary adrenal insufficiency (250-microg cosyntropin test), secondary adrenal insufficiency (250-
22 aracteristics of the 250-microg and 1-microg cosyntropin tests are similar.
23 1), but AUCs for the 250-microg and 1-microg cosyntropin tests did not differ significantly (P > 0.5)
24 specificity data for 250-microg and 1-microg cosyntropin tests; these curves were then compared by us
25 eralization has been primarily attributed to cosyntropin use and lateralization index thresholds.
26                         Cortisol response to cosyntropin varies considerably among healthy persons.
27 level <20 microg/dL post-low-dose (1 microg) cosyntropin was considered diagnostic of adrenal insuffi